Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study

EYESHOT Post-MI Investigators

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.

Original languageEnglish
Pages (from-to)8-14
JournalInternational Journal of Cardiology
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Myocardial Infarction
Cardiologists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Percutaneous Coronary Intervention
Coronary Angiography
Stents
Observational Studies
Registries
Therapeutics
Population

Keywords

  • Clopidogrel
  • Dual antiplatelet therapy
  • Percutaneous coronary intervention
  • Post-MI
  • Secondary prevention
  • Ticagrelor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{29a573b610be45dba0414cf3f8e2cf1c,
title = "Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study",
abstract = "Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0{\%}) at the second and 605 (37.0{\%}) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60{\%} and 54{\%}), followed by coronary angiography (24{\%} and 16{\%}, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93{\%}) and beta-blockers (82{\%}), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40{\%} vs 24{\%}; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95{\%} CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95{\%} CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.",
keywords = "Clopidogrel, Dual antiplatelet therapy, Percutaneous coronary intervention, Post-MI, Secondary prevention, Ticagrelor",
author = "{EYESHOT Post-MI Investigators} and {De Luca}, Leonardo and Federico Piscione and Furio Colivicchi and Donata Lucci and Franco Mascia and Barbara Marinoni and Plinio Cirillo and Daniele Grosseto and Ciro Mauro and Paolo Calabr{\`o} and Federico Nardi and Roberta Rossini and Giovanna Geraci and Domenico Gabrielli and {Di Lenarda}, Andrea and Gulizia, {Michele Massimo}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ijcard.2018.08.055",
language = "English",
pages = "8--14",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction

T2 - The EYESHOT Post-MI study

AU - EYESHOT Post-MI Investigators

AU - De Luca, Leonardo

AU - Piscione, Federico

AU - Colivicchi, Furio

AU - Lucci, Donata

AU - Mascia, Franco

AU - Marinoni, Barbara

AU - Cirillo, Plinio

AU - Grosseto, Daniele

AU - Mauro, Ciro

AU - Calabrò, Paolo

AU - Nardi, Federico

AU - Rossini, Roberta

AU - Geraci, Giovanna

AU - Gabrielli, Domenico

AU - Di Lenarda, Andrea

AU - Gulizia, Michele Massimo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.

AB - Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.

KW - Clopidogrel

KW - Dual antiplatelet therapy

KW - Percutaneous coronary intervention

KW - Post-MI

KW - Secondary prevention

KW - Ticagrelor

UR - http://www.scopus.com/inward/record.url?scp=85052745675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052745675&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2018.08.055

DO - 10.1016/j.ijcard.2018.08.055

M3 - Article

AN - SCOPUS:85052745675

SP - 8

EP - 14

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -